Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

2 treatments under study, led by Standard Treatment

Research Leaders

12 sponsors active, led by Jimma University

Related Conditions

Often studied with 10 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

Trial Status

Completed2
Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 2 completed trials

Clinical Trials (3)

Research Network

Common Treatments

  • Standard Treatment1
  • Questionnaire And Physical Exam1

Active Sponsors

  • Jimma University1
  • Meng Chao Hepatobiliary Hospital of Fujian Medical University1
  • Taihe Hospital1
  • The First Hospital of Jilin University1
  • Xiangya Hospital of Central South University1

Top Investigators

Related Conditions

  • Platelet1
  • Acute On Chronic Liver Failure1
  • Longterm Outcomes1
  • Thrombelastography1
  • Complications Of Surgical Procedures Or Medical Care1

Activity Timeline